Skip to main content
Erschienen in: Drugs & Aging 10/2005

01.10.2005 | Current Opinion

Asymptomatic Bacteriuria in Elderly Patients

Significance and Implications for Treatment

verfasst von: Dr Florian M. E. Wagenlehner, Kurt G. Naber, Wolfgang Weidner

Erschienen in: Drugs & Aging | Ausgabe 10/2005

Einloggen, um Zugang zu erhalten

Abstract

Asymptomatic bacteriuria (ASB) is frequent in elderly patients and even more prevalent in residents of long-term care facilities. Furthermore, because more and more people are reaching advanced age and the need for care increases with age, ASB is becoming increasingly important.
There are several definitions for ASB, all of which require positive urine cultures and place little or no importance on accompanying pyuria. Most ASB is associated with complicating factors, as might be found in complicated urinary tract infections (UTIs). Thus, the bacterial spectrum associated with ASB is comparable to that seen in complicated UTIs. A variety of complicating factors are more frequently found in elderly patients with ASB, such as hormonal factors (e.g. estrogen decrease), certain anatomical factors (e.g. prostate obstruction), metabolic factors (e.g. diabetes mellitus), functional alteration of the urinary bladder, immunological changes and a high rate of indwelling-catheter use.
Screening for ASB in elderly people is limited to those undergoing invasive urological procedures and surgical procedures with implant material. In other situations, examination of the urine is not recommended if signs or symptoms in the urinary tract are absent.
Treatment of ASB is recommended only before urological procedures. Pyuria accompanying ASB is not an indication for antimicrobial treatment. If antimicrobial treatment is considered, concomitant factors that occur frequently in elderly people, such as renal insufficiency, must be taken into account.
Although ASB is apparently a benign condition, prevention in elderly people is important. The degree of pathogenicity of bacteria causing ASB has not yet been satisfactorily elucidated. Therefore, until the implications of the bacteria involved in ASB are fully understood, implementing the same hygienic precautions as are used in individuals with symptomatic UTIs should at least be undertaken.
Literatur
1.
Zurück zum Zitat Gomolin IH, McCue JD. Urinary tract infection in the elderly patient. Infect Urol 2000; 13Suppl. 5a: 7–13 Gomolin IH, McCue JD. Urinary tract infection in the elderly patient. Infect Urol 2000; 13Suppl. 5a: 7–13
2.
Zurück zum Zitat Baldassarre JS, Kaye D. Special problems of urinary tract infection in the elderly. Med Clin North Am 1991; 75: 375–90PubMed Baldassarre JS, Kaye D. Special problems of urinary tract infection in the elderly. Med Clin North Am 1991; 75: 375–90PubMed
3.
Zurück zum Zitat Boscia JA, Kobasa WD, Knight RA, et al. Epidemiology of bacteriuria in an elderly ambulatory population. Am J Med 1986; 80: 208–14PubMedCrossRef Boscia JA, Kobasa WD, Knight RA, et al. Epidemiology of bacteriuria in an elderly ambulatory population. Am J Med 1986; 80: 208–14PubMedCrossRef
4.
Zurück zum Zitat Nicolle LE. Urinary tract infections in the elderly: symptomatic or asymptomatic? Int J Antimicrobiol Agents 1999; 11: 265–8CrossRef Nicolle LE. Urinary tract infections in the elderly: symptomatic or asymptomatic? Int J Antimicrobiol Agents 1999; 11: 265–8CrossRef
5.
Zurück zum Zitat Nicolle LE. The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol 2001; 22: 316–21PubMedCrossRef Nicolle LE. The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol 2001; 22: 316–21PubMedCrossRef
6.
Zurück zum Zitat Weidner W, Hochreiter W, Liedl B, et al. Urogenitale Infektionen im Alter. Urologe A 2002; 41: 328–32PubMedCrossRef Weidner W, Hochreiter W, Liedl B, et al. Urogenitale Infektionen im Alter. Urologe A 2002; 41: 328–32PubMedCrossRef
7.
Zurück zum Zitat Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 1956; 69: 56–64PubMed Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 1956; 69: 56–64PubMed
8.
Zurück zum Zitat Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–40PubMedCrossRef Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–40PubMedCrossRef
9.
Zurück zum Zitat Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643–54PubMedCrossRef Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643–54PubMedCrossRef
10.
Zurück zum Zitat Nicolle LE. Asymptomatic bacteriuria in institutionalized elderly people: evidence and practice. CMAJ 2000; 163: 285–6PubMed Nicolle LE. Asymptomatic bacteriuria in institutionalized elderly people: evidence and practice. CMAJ 2000; 163: 285–6PubMed
11.
Zurück zum Zitat Raz R. Asymptomatic bacteriuria: clinical significance and management. Int J Antimicrob Agents 2003; 22: 45–7PubMedCrossRef Raz R. Asymptomatic bacteriuria: clinical significance and management. Int J Antimicrob Agents 2003; 22: 45–7PubMedCrossRef
12.
Zurück zum Zitat Wullt B. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents 2003; 21: 605–21PubMedCrossRef Wullt B. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents 2003; 21: 605–21PubMedCrossRef
13.
Zurück zum Zitat Hull AR, Donovan WH, Del Terzo M, et al. Role of type 1 fimbria- and p fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect Immun 2002; 70: 6481–4PubMedCrossRef Hull AR, Donovan WH, Del Terzo M, et al. Role of type 1 fimbria- and p fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect Immun 2002; 70: 6481–4PubMedCrossRef
14.
Zurück zum Zitat Hultgren SJ, Porter TN, Schaeffer AJ, et al. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun 1985; 50: 370–7PubMed Hultgren SJ, Porter TN, Schaeffer AJ, et al. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun 1985; 50: 370–7PubMed
15.
Zurück zum Zitat Wullt B, Bergsten G, Connell H, et al. P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol 2000; 38: 456–64PubMedCrossRef Wullt B, Bergsten G, Connell H, et al. P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol 2000; 38: 456–64PubMedCrossRef
16.
Zurück zum Zitat Johnson JR. Host-pathogen interactions in Escherichia coli urinary tract infections. Curr Opin Infect Dis 1994; 7: 287–94CrossRef Johnson JR. Host-pathogen interactions in Escherichia coli urinary tract infections. Curr Opin Infect Dis 1994; 7: 287–94CrossRef
17.
Zurück zum Zitat Wagenlehner FME, Niemetz A, Dalhoff A, et al. Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994–2000. Int J Antimicrob Agents 2002; 19: 557–64PubMedCrossRef Wagenlehner FME, Niemetz A, Dalhoff A, et al. Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994–2000. Int J Antimicrob Agents 2002; 19: 557–64PubMedCrossRef
18.
Zurück zum Zitat Wagenlehner FM, Naber KG. Antibiotics and resistance of uropathogens. Eur Urol 2004; 2: 125–35 Wagenlehner FM, Naber KG. Antibiotics and resistance of uropathogens. Eur Urol 2004; 2: 125–35
19.
Zurück zum Zitat George NJR. Urinary tract infection. In: Mundy AR, Fitzpatrick JM, Neal DE, et al., editors. The scientific basis of urology. Oxford: ISIS medical media, 1999 George NJR. Urinary tract infection. In: Mundy AR, Fitzpatrick JM, Neal DE, et al., editors. The scientific basis of urology. Oxford: ISIS medical media, 1999
20.
Zurück zum Zitat Stamm WE, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 1999; 28: 723–5PubMedCrossRef Stamm WE, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 1999; 28: 723–5PubMedCrossRef
21.
Zurück zum Zitat Geerlings SE, Stolk RP, Camps MJL, et al. Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care 2000; 23: 1737–41PubMedCrossRef Geerlings SE, Stolk RP, Camps MJL, et al. Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care 2000; 23: 1737–41PubMedCrossRef
22.
Zurück zum Zitat Ronald A, Ludwig E. Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 2000; 17: 287–92CrossRef Ronald A, Ludwig E. Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 2000; 17: 287–92CrossRef
23.
Zurück zum Zitat Hoepelmann AIM, Meiland R, Geerlings S. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents 2003; 22: 35–43CrossRef Hoepelmann AIM, Meiland R, Geerlings S. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents 2003; 22: 35–43CrossRef
24.
Zurück zum Zitat Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39: 687–99PubMedCrossRef Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39: 687–99PubMedCrossRef
25.
Zurück zum Zitat Orr PH, Nicolle LE, Duckworth H, et al. Febrile urinary infection in the institutionalized elderly. Am J Med 1996; 100: 71–7PubMedCrossRef Orr PH, Nicolle LE, Duckworth H, et al. Febrile urinary infection in the institutionalized elderly. Am J Med 1996; 100: 71–7PubMedCrossRef
26.
Zurück zum Zitat Ouslander JG, Greengold B, Chen S. Complications of chronic indwelling urinary catheters among male nursing home patients: a prospective study. J Urol 1987; 138: 1191–5PubMed Ouslander JG, Greengold B, Chen S. Complications of chronic indwelling urinary catheters among male nursing home patients: a prospective study. J Urol 1987; 138: 1191–5PubMed
27.
Zurück zum Zitat Warren JW, Munci HL, Hall-Craggs M. Acute pyelonephritis associated with bacteriuria during long-term catheterization: a prospective clinicopathological study. J Infect Dis 1988; 158: 1341–6PubMedCrossRef Warren JW, Munci HL, Hall-Craggs M. Acute pyelonephritis associated with bacteriuria during long-term catheterization: a prospective clinicopathological study. J Infect Dis 1988; 158: 1341–6PubMedCrossRef
28.
Zurück zum Zitat Nicolle LE. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am 1997; 11: 647–62PubMedCrossRef Nicolle LE. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am 1997; 11: 647–62PubMedCrossRef
29.
Zurück zum Zitat Harding KM, Zhanel GG, Nicolle LE, et al. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002; 347: 1576–83PubMedCrossRef Harding KM, Zhanel GG, Nicolle LE, et al. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002; 347: 1576–83PubMedCrossRef
30.
Zurück zum Zitat Schmucker DL. Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging 2001; 18: 837–51PubMedCrossRef Schmucker DL. Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging 2001; 18: 837–51PubMedCrossRef
31.
Zurück zum Zitat Naber KG, Fünfstück R, Hofstetter A, et al. Empfehlungen zur antimikrobiellen Therapie von Infektionen der Nieren und des Urogenitaltraktes bei Erwachsenen. Chemotherapie Journal 2000; 6: 193–9 Naber KG, Fünfstück R, Hofstetter A, et al. Empfehlungen zur antimikrobiellen Therapie von Infektionen der Nieren und des Urogenitaltraktes bei Erwachsenen. Chemotherapie Journal 2000; 6: 193–9
32.
Zurück zum Zitat Dettli L. Translation of pharmacokinetics to clinical medicine. J Pharmacokinet Biopharm 1973; 1: 403–18PubMed Dettli L. Translation of pharmacokinetics to clinical medicine. J Pharmacokinet Biopharm 1973; 1: 403–18PubMed
33.
Zurück zum Zitat Kunin CM. A guide to the use of antibiotics in patients with renal disease: a table of recommended doses and factors governing serum levels. Am Intern Med 1967; 67: 151–8 Kunin CM. A guide to the use of antibiotics in patients with renal disease: a table of recommended doses and factors governing serum levels. Am Intern Med 1967; 67: 151–8
34.
Zurück zum Zitat Vahlensieck Jr W. Prophylaxemaßnahmen bei rezidivierenden Harnwegsinfektionen. In: Hofstetter A, (Hrsg) Urogenitale Infektionen. Berlin: Springer, 1999: 215–239CrossRef Vahlensieck Jr W. Prophylaxemaßnahmen bei rezidivierenden Harnwegsinfektionen. In: Hofstetter A, (Hrsg) Urogenitale Infektionen. Berlin: Springer, 1999: 215–239CrossRef
35.
Zurück zum Zitat Jepson RG, Mihaljevic L, Craig JC. Cranberries for preventing urinary tract infections (Cochrane review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 4. Oxford: Update Software, 2003 Jepson RG, Mihaljevic L, Craig JC. Cranberries for preventing urinary tract infections (Cochrane review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 4. Oxford: Update Software, 2003
36.
Zurück zum Zitat Lowe FC, Fagelman E. Cranberry juice and urinary tract infections: what is the evidence? Urology 2001; 57: 407–13PubMedCrossRef Lowe FC, Fagelman E. Cranberry juice and urinary tract infections: what is the evidence? Urology 2001; 57: 407–13PubMedCrossRef
37.
Zurück zum Zitat Lee B, Bhuta T, Craig J, et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2002; (1): CD003265 Lee B, Bhuta T, Craig J, et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2002; (1): CD003265
38.
Zurück zum Zitat Lutters M, Vogt N. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev 2002; (3): CD001535 Lutters M, Vogt N. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev 2002; (3): CD001535
39.
Zurück zum Zitat Mack DJ, Smart L, Girdwood A, et al. Infection prophylaxis with lactulose [letter]. Age Ageing 1993; 22Suppl. 2: 8CrossRef Mack DJ, Smart L, Girdwood A, et al. Infection prophylaxis with lactulose [letter]. Age Ageing 1993; 22Suppl. 2: 8CrossRef
40.
Zurück zum Zitat McCutcheon J, Fulton JD. Lowered prevalence of infection with lactulose therapy in patients in long-term hospital care. J Hosp Infect 1989; 13: 81–6PubMedCrossRef McCutcheon J, Fulton JD. Lowered prevalence of infection with lactulose therapy in patients in long-term hospital care. J Hosp Infect 1989; 13: 81–6PubMedCrossRef
41.
Zurück zum Zitat Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753–6PubMedCrossRef Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753–6PubMedCrossRef
Metadaten
Titel
Asymptomatic Bacteriuria in Elderly Patients
Significance and Implications for Treatment
verfasst von
Dr Florian M. E. Wagenlehner
Kurt G. Naber
Wolfgang Weidner
Publikationsdatum
01.10.2005
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 10/2005
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200522100-00001

Weitere Artikel der Ausgabe 10/2005

Drugs & Aging 10/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.